Chief Medical Officer
Protein Sciences Corporation
Pediatric Infectious Disease
Dr. Lisa M. Dunkle practices Pediatric Infectious Disease. She studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine She has 1 awards "Distinguished Alumna Award". Dr. Lisa M. Dunkle is a published physician. She published 23 publications, including: 'Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial...'
Publications
- Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age.
- Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5.
- Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trial.
- Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blin...
- Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex.
- Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
- Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
- Design and implementation of the stavudine parallel-track program.
- Rapid microprocedure for extraction of plasmid DNA from Staphylococcus aureus.
- Changing presentation of herpes simplex virus infection in neonates.
- Transformation of a plasmid encoding an adhesin of Staphylococcus aureus into a nonadherent staphylococcal strain.
- Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
- Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection.
- A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
- Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian H...
- Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine.
- Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic...
- Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial...
- Dose-related activity of stavudine in patients infected with human immunodeficiency virus.
- Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
- The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
- Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults.
Schools
Johns Hopkins University School of Medicine
Washington USt Louis Chldn
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Distinguished Alumna Award
Education
-
Johns Hopkins University School of Medicine
Helpful Reviews
Give
Anonymous Review
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.